Dr. Joren Brassine

Active

Private limited companyfounded 20233 yrs activeCoupure 105, 9000 Gent, BelgiumKBO/BCE: BE 0797.856.771

Dr. Joren Brassine has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €85k and a net result of €34k. Equity is growing by ~41.4% per year across the filed fiscal years. Its solvency ranks better than 28% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Watch Print / PDF

Checked score

Score 2025

75 / 100

Excellent

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability85▲+11

Solvency59▲+12

Growth52=

Track record94

Bankruptcy probability, 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

Credit up to €6k at 30 days acceptable

Liquidity ample (current ratio 1.84 against 0.88 in 2024; short-term debt: 7.6% and cash: 3.4% of total assets), but 66.5% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 86

Relative position

BE, all sectors

reference

Sector 86

lower

← fewer bankruptcies more bankruptcies →

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

Annual accounts: healthy financial profile

The latest annual accounts show a healthy profile in solvency, result and liquidity.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

33.5%

Return on assets

13.4%

Age of the figures

9 mo

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-03-2026, 148 days ahead of the deadline.

NBB · 3 filings

Deviation from the deadline

2025

148 d early

2024

on the day

2023

40 d early

← before the deadline after the deadline →

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

22-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity

€85k▲ 66.4%

2024 · €51k

2023: €43k 2024: €51k

2023 → 2025

Total assets

€255k▲ 9.3%

2024 · €233k

2023: €48k 2024: €233k

2023 → 2025

Net result

€34k▲ 270%

2024 · €9k

2023: €38k 2024: €9k

2023 → 2025

Working capital

€16k

2024 · €-2k

2023: €42k 2024: €-2k

2023 → 2025

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line202320242025Trend

Equity€43k-€51k▲ 19.6%€85k▲ 66.4%

Operating result€48k-€16k▼ 65.9%€50k▲ 204%

Net result€38k-€9k▼ 75.7%€34k▲ 270%

Turnover and EBIT margin not published: the micro schema does not require them.

Result per fiscal year

Operating resultNet result

The operating result recovers in 2025; 2025 is 204% above 2024 and is the highest result in the available series.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €255k

86.0%

14.0%

Fixed assets €219k▲ 1.2%

Current assets €36k▲ 116%

Equity and liabilities €255k

33.5%

66.5%

Equity €85k▲ 66.4%

Debt €169k▼ 6.8%

The debt ratio falls from 78.0% to 66.5%. Equity is higher and debt is lower.

Key figures and ratios

2025 value · change against 2024

EBITDA

€67k▲

2024 · €30k

Cash flow

€51k▲

2024 · €22k

Solvency

33.5%▲

2024 · 22.0%

Current ratio

1.84▲

2024 · 0.88

Quick ratio

1.84▲

2024 · 0.88

Debt / equity

1.98▼

2024 · 3.54

ROE

39.9%▲

2024 · 18.0%

ROA

13.4%▲

2024 · 3.9%

Interest coverage

9.62▲

2024 · 7.71

Debt

€169k▼

2024 · €182k

Debt ≤ 1 year

€19k▲

2024 · €19k

Debt > 1 year

€150k▼

2024 · €163k

Income taxes

€9k▲

2024 · €3k

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2025 against 2024

Balance sheet Code20242025

Assets

Total assets20/58€233k€255k▲

Fixed assets21/28€216k€219k▲

Tangible fixed assets22/27€216k€219k▲

Land and buildings22€171k€172k▲

Plant, machinery and equipment23-€11k

Furniture and vehicles24€45k€37k▼

Current assets29/58€16k€36k▲

Amounts receivable within one year40/41€15k€25k▲

Trade receivables40€9k€19k▲

Other amounts receivable41€5k€6k▲

Cash at bank and in hand54/58€0€9k▲

Deferred charges and accrued income490/1€2k€2k▼

Equity and liabilities

Total equity and liabilities10/49€233k€255k▲

Equity10/15€51k€85k▲

Contributions10/11€5k€5k=

Reserves13€46k€80k▲

Distributable reserves133€46k€80k▲

Profit (loss) carried forward14€0€0=

Amounts payable17/49€182k€169k▼

Amounts payable after more than one year17€163k€150k▼

Financial debts170/4€163k€150k▼

Amounts payable within one year42/48€19k€19k▲

Current portion of amounts payable after more than one year42€13k€13k▲

Trade debts44€704€189▼

Suppliers440/4€704€189▼

Taxes, remuneration and social security45€5k€6k▲

Taxes450/3€3k€6k▲

Remuneration and social security454/9€2k€0▼

Other amounts payable47/48€560€0▼

Income statement Code20242025

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€17k▲

Other operating charges640/8€388€990▲

Gross operating margin9900€30k€68k▲

Operating profit (loss)9901€16k€50k▲

Financial income75/76B-€121

Recurring financial income75-€121

Financial charges65/66B€4k€7k▲

Recurring financial charges65€4k€7k▲

Profit (loss) for the period before taxes9903€13k€43k▲

Income taxes67/77€3k€9k▲

Profit (loss) for the period9904€9k€34k▲

Profit (loss) for the period to be appropriated9905€9k€34k▲

Appropriation of the result

Profit (loss) to be appropriated9906€9k€34k▲

Transfer to equity691/2€8k€34k▲

To other reserves6921€8k€34k▲

Profit to be distributed694/7€800€0▼

Return on contributions (dividend)694€800€0▼

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 5Financial 2Filings 3

Next filing, fiscal year 2026, expected by 31-07-2027

2026

05-03

NBB filing Annual accounts filed

fiscal year 2025 · micro schema

2025

31-12

Financial Liquidity doublescurrent ratio 1.84

Current ratio from 0.88 to 1.84.

31-07

NBB filing Annual accounts filed

fiscal year 2024 · micro schema

2024

31-12

Financial Weakest financial yearnet €9k ▼75.7%

Net result drops to €9k, the lowest in the series; recovery starts the following year.

21-06

NBB filing Annual accounts filed

fiscal year 2023 · micro schema

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.

Location & real-estate footprint

Registered office, Gent · 1 establishment unit since 2023

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Coupure 1059000 Gent

Ground area

453 m²

Building footprint

192 m²

Volume, LiDAR

2,571 m³

Parcel 44806F0674/00G003, Flanders · tallest building 19.7 m, ±5 floors. Linked by address, not a title deed.

1 establishment unit

Dr. Joren Brassine

Coupure 105, 9000 GentSpecialist medical practice

since 20232.341.392.631

1 parcel

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
44806F0674/00G003 ProtectedMonument · Townscape or village viewBlindenhuis Van Caeneghemgesticht en Pharmacodynamisch Instituut met omgevingSource ↗	Flanders	453 m²	1 · 192 m²	19.7 m · 5 fl.